Mainland China
vivo officially launches VISION+ Mobile PhotoAwards 2021
vivo partners with National Geographic to host professional mobile photography competition BEIJING, June 7, 2021 /PRNewswire/ -- Today vivo officially launched the VISION+ Mobile PhotoAwards 2021 (hereafter referred to as VISION+ Mobile PhotoAwards), in partnership with National Geographic,...
KYMCO Announces Ionex EV League
BEIJING, June 7, 2021 /PRNewswire/ -- At the Beijing International Motorcycle
Exhibition 2021, KYMCO announces Ionex EV League strategic alliance with Super
SOCO and FELO Technology.
Nium Signs Definitive Agreement to Acquire B2B Travel Payments Leader Ixaris
SINGAPORE and LONDON, June 7, 2021 /PRNewswire/ -- Nium, a leading global B2B payments platform, today announced that it has signed a definitive agreement to acquire Ixaris, a leader in travel payments optimisation. The transaction is expected to close early in the third quarter of 2021, subject ...
China makes great efforts to contain COVID-19, saves more lives: SCO Secretary-General
WUHAN, China, June 4, 2021 /PRNewswire/ -- China has made great efforts to contain the spread of COVID-19 and saved more lives, Secretary-General of the Shanghai Cooperation Organization (SCO) Vladimir Norov told Global Times Online on the sidelines of the SCO non-governmental friendship forum he...
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Plus Paclitaxel/Cisplatin for the First-line Treatment of ESCC at ASCO 2021
SUZHOU, China, June 7, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced data from Phase 2 clinical study (KN046-204) of KN046(PD-L1/CTLA-4 bispecific antibody) plus paclitaxel/cisplatin for the first-line treatment of unresectable locally advanced, recurrent or metastatic e...
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021
* KN046 combined with platinum doublet chemotherapy is tolerated and has shown promising clinical benefit as IL treatment for stage IV NSCLC. * OS rate at 12 months and 15 months were both 74.9%; Similar survival was observed in patients with PD-L1≥1% and PD-L1<1%; * the median progression-f...
OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting
SHANGHAI, June 7, 2021 /PRNewswire/ -- On June 4, 2021 (EST), OriginCell Therapeutics (Shanghai) Co., Ltd. ("OriginCell"), together with Lishui Central Hospital affiliated toZhejiang University and Shanghai Changzheng Hospital, presented the updated data from the on-going trial of Ori-CAR-001,...
Hyperice Named Official Recovery Technology Partner by League of Legends Pro League
SHANGHAI, June 7, 2021 /PRNewswire/ -- League of Legends Pro League (LPL) and Hyperice, the industry leader in recovery technology and pioneer of percussion, vibration, dynamic air compression and thermal technology, today announced a partnership that names Hyperice the league's Official Recovery...
Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021
* As of January 15, 2021, 9 patients were included in the efficacy analysis and 17 patients in the safety analysis. ORR was 55.6%, and DCR was 88.9%. * The updated results from this Phase II study will be presented at an upcoming medical meeting. A phase III clinical study of KN046 in combinat...
CSOP Asset Management Ltd. Chooses SS&C to Support Operations
WINDSOR, Conn., June 7, 2021 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced thatHong Kong's CSOP Asset Management Ltd. has selected Eze Investment Suite for order management and portfolio accounting. Eze Investment Suite provides the flexibility CSOP required for ...
WeBank and SMU Nurture Future-Ready Fintech Talent with Blockchain Courses
SHENZHEN, China, June 7, 2021 /PRNewswire/ -- WeBank, the world's leading digital bank and the first digital-only bank inChina, announced that its summer enrichment programme onFISCO BCOS[1] Blockchain Experience at the Singapore Management University (SMU), a premier university in Asia internati...
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication
HANGZHOU, China and SHAOXING, China, June 7, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its drug candidate ASC42 to conduct clinical trials for ch...
Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting
SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries
ISSAQUAH, Wash. and SHANGHAI, June 7, 2021 /PRNewswire/ -- Arctic Vision, a clinical stage biotech company focusing on innovative ophthalmology therapies for pan-ocular diseases, and Olympic Ophthalmics, a U.S.-based medical technology company pioneering neuromodulation treatments for ophthalmic ...
Wood Mackenzie announces inaugural Power & Renewables APAC Conference
Industry leaders to discuss climate change policies and net-zero impact on APAC markets First public presentation of Wood Mackenzie Lens® Power SINGAPORE, June 7, 2021 /PRNewswire/ -- Wood Mackenzie invites registration for its inaugural Power & Renewables Asia Pacific (APAC) Conference onJune 2...
Primavera Capital Acquires Greater China Business of Mead Johnson from Reckitt Benckiser Group
BEIJING, June 6, 2021 /PRNewswire/ -- Primavera Capital Group ("Primavera") today announces that it has signed a definitive agreement with Reckitt Benckiser Group plc ("Reckitt"), a world's leading consumer health, nutrition, and hygiene company, to acquire theGreater China business of the Mead J...
Ucommune International Ltd. Announces Unaudited First Quarter 2021 Financial Results
BEIJING, Jun. 5, 2021 /PRNewswire/ -- Ucommune International Ltd. (NASDAQ: UK) ("Ucommune" or the "Company"), a leading agile office space manager and provider inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2021. First Quarter 2021 Financial Highli...
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38Tan Xuguang: Unveiling New Quality Productivity in Power Solutions for Asia-Pacific Data Centers!
[Picked up by 302 media titles]
2024-06-19 21:25